▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extreme 7.265625
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.156005859375
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.12237548828125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.32080078125
▁countries 0.91796875
. 0.63671875
▁The 2.119140625
▁introduction 7.75390625
▁of 0.0309906005859375
▁the 2.359375
▁study 7.3203125
▁describes 7.28125
▁the 0.57568359375
▁apparent 8.9140625
▁link 4.6875
▁between 0.2440185546875
▁pain 2.71484375
▁and 0.294921875
▁dem 7.14453125
oral 3.392578125
ization 0.1217041015625
. 1.046875
▁Chron 4.515625
ic 0.0032444000244140625
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.60546875
▁accompanied 2.984375
▁by 0.1500244140625
▁negative 4.1484375
▁emot 0.9111328125
ional 1.3955078125
▁experiences 2.984375
▁and 2.080078125
▁blocks 11.3046875
▁a 3.341796875
▁person 0.69140625
’ 0.876953125
s 0.001071929931640625
▁ability 1.3916015625
▁to 0.036834716796875
▁receive 6.84375
▁joy 3.732421875
▁and 1.376953125
▁satisfaction 3.255859375
▁from 0.86572265625
▁life 0.7919921875
. 0.2283935546875
▁The 1.64453125
▁research 2.6875
▁investig 5.40625
ates 0.38720703125
▁the 0.38720703125
▁development 6.15625
▁of 0.1458740234375
▁de 3.841796875
pression 0.45849609375
▁and 1.3544921875
▁anx 1.6201171875
iety 0.0010986328125
▁among 1.6044921875
▁patients 1.48046875
▁receiving 5.83203125
▁ph 5.48046875
arma 3.224609375
ce 0.01218414306640625
ut 6.604194641113281e-05
ical 0.0064239501953125
▁op 4.64453125
io 0.09832763671875
ids 0.440185546875
▁and 2.4921875
▁medical 4.05859375
▁mar 1.75
iju 0.0010881423950195312
ana 4.851818084716797e-05
▁( 2.958984375
MM 1.2978515625
) 2.8984375
▁as 2.44140625
▁severe 9.9921875
▁pain 0.78271484375
kill 2.65625
ers 0.0005288124084472656
. 0.2169189453125
▁It 3.259765625
▁comp 4.98046875
ares 0.008392333984375
▁the 0.59033203125
▁effic 4.30859375
acy 0.0018768310546875
▁of 0.2039794921875
▁pres 6.08984375
cri 1.9091796875
ptions 1.451171875
▁and 1.927734375
▁exam 4.49609375
ines 0.00995635986328125
▁the 0.47314453125
▁possibility 3.95703125
▁of 0.132080078125
▁post 8.203125
- 0.5849609375
tre 1.9677734375
at 0.0017747879028320312
ment 0.004730224609375
▁de 1.6396484375
pression 0.081298828125
. 1.384765625
<0x0A> 0.767578125
There 4.6640625
▁is 1.1904296875
▁currently 5.5546875
▁a 1.0595703125
▁severe 4.9296875
▁lack 1.8564453125
▁of 0.014617919921875
▁information 2.271484375
▁about 1.162109375
▁the 0.47021484375
▁effects 3.1015625
▁of 0.0631103515625
▁op 3.08203125
i 3.7109375
ates 0.011688232421875
. 3.380859375
▁They 4.52734375
▁manage 8.40625
▁pain 3.39453125
▁successfully 5.81640625
, 0.97412109375
▁but 0.234375
▁the 2.478515625
▁past 9.0546875
▁few 2.25
▁dec 1.248046875
ades 0.0006232261657714844
▁indicated 7.015625
▁the 1.73828125
▁growing 3.603515625
▁concern 3.3828125
▁regarding 2.716796875
▁op 2.5546875
iate 1.0869140625
▁ab 1.5830078125
use 0.01509857177734375
▁in 3.8359375
▁forms 8.859375
▁of 0.25048828125
▁over 3.283203125
d 0.1043701171875
ose 0.3251953125
▁and 0.701171875
▁add 0.701171875
iction 0.01934814453125
. 0.1365966796875
▁A 4.0390625
▁more 4.79296875
▁manage 7.921875
able 0.0005059242248535156
▁and 2.11328125
▁sa 2.064453125
fer 0.000156402587890625
▁alternative 1.3193359375
▁might 5.10546875
▁be 0.11883544921875
▁medical 1.5791015625
▁mar 0.1561279296875
iju 0.0006966590881347656
ana 9.66787338256836e-05
. 0.95166015625
▁However 3.326171875
, 0.00254058837890625
▁the 1.6845703125
▁legal 3.953125
▁status 1.1416015625
▁and 3.126953125
▁novel 9.84375
ty 0.133056640625
▁of 0.1466064453125
▁this 2.33203125
▁drug 1.37890625
▁do 4.359375
▁not 0.0124359130859375
▁allow 0.69873046875
▁finding 6.921875
▁a 2.380859375
▁large 2.556640625
▁number 0.78515625
▁of 0.0020751953125
▁studies 1.2890625
▁on 1.767578125
▁its 0.7998046875
▁effect 2.37109375
iveness 0.1767578125
. 0.64306640625
▁Specifically 8.9765625
, 0.04681396484375
▁it 2.630859375
▁concerns 5.05078125
▁the 0.81689453125
▁emot 6.55859375
ional 0.01873779296875
▁condition 4.6015625
▁of 0.2186279296875
▁patients 0.67626953125
▁experien 5.25
cing 1.6450881958007812e-05
▁chron 0.80908203125
ic 0.0003542900085449219
▁pain 0.050323486328125
. 0.437255859375
▁This 2.923828125
▁research 1.8896484375
▁paper 4.05078125
▁a 1.8330078125
ims 0.0005173683166503906
▁to 0.11553955078125
▁analyze 3.291015625
▁levels 9.9296875
▁of 0.0205535888671875
▁de 0.494140625
pression 0.023956298828125
▁and 0.1829833984375
▁anx 0.024078369140625
iety 0.0004162788391113281
▁among 0.74365234375
▁people 2.482421875
▁receiving 2.236328125
▁ther 6.6171875
apy 0.1036376953125
▁by 4.546875
▁comparing 8.8515625
▁the 1.5341796875
▁effects 2.150390625
▁of 0.023895263671875
▁ph 2.94921875
arma 0.0309295654296875
ce 0.0031757354736328125
ut 9.85860824584961e-05
ical 0.00360107421875
▁op 0.11798095703125
io 0.61865234375
ids 0.0305633544921875
▁and 0.242919921875
▁MM 0.476806640625
. 0.252685546875
<0x0A> 0.449951171875
The 0.74853515625
▁study 1.7197265625
▁was 2.326171875
▁conducted 0.64794921875
▁in 1.25
▁the 1.3974609375
▁form 2.576171875
▁of 0.0017671585083007812
▁collection 11.78125
▁and 0.666015625
▁analysis 0.387451171875
▁of 0.00922393798828125
▁statistical 3.814453125
▁data 0.11712646484375
. 0.87548828125
▁Part 5.2109375
icip 0.2474365234375
ants 0.0618896484375
▁were 0.69287109375
▁rec 3.564453125
ru 0.0008072853088378906
ited 0.00026345252990722656
▁for 4.06640625
▁six 6.83984375
▁months 0.470458984375
▁at 3.771484375
▁two 2.58984375
▁major 3.90625
▁pain 2.68359375
▁relief 4.15625
▁cent 0.8447265625
ers 0.025665283203125
▁in 0.6533203125
▁Israel 5.50390625
. 0.32666015625
▁The 1.2099609375
▁research 2.40625
ers 1.3623046875
▁used 2.216796875
▁The 7.12890625
▁De 2.9453125
pression 0.0222015380859375
▁Module 6.71875
▁of 0.7158203125
▁the 0.221923828125
▁Pat 3.28515625
ient 0.00891876220703125
▁Health 0.031890869140625
▁Question 0.017913818359375
naire 0.0244598388671875
▁and 2.71875
▁the 0.85107421875
▁General 1.201171875
ized 0.61328125
▁An 0.004802703857421875
x 8.726119995117188e-05
iety 0.00039505958557128906
▁Dis 0.18115234375
order 0.01995849609375
▁Sc 1.4453125
ale 0.00275421142578125
▁to 0.91259765625
▁interview 7.60546875
▁participants 2.748046875
, 4.359375
▁evaluate 4.53125
▁their 0.5390625
▁answers 4.234375
, 0.320068359375
▁and 0.03399658203125
▁conduct 5.015625
▁the 1.8271484375
▁study 2.4375
. 0.09918212890625
▁To 4.8203125
▁specifically 9.9296875
▁evaluate 3.298828125
▁and 5.109375
▁compare 0.5107421875
▁the 0.400390625
▁prob 9.96875
abilities 0.05755615234375
▁of 0.070068359375
▁de 0.85595703125
pression 0.03509521484375
▁or 4.4140625
▁anx 0.04583740234375
iety 0.0005784034729003906
▁among 1.3701171875
▁the 2.16015625
▁diverse 9.734375
▁groups 0.78125
, 0.78076171875
▁the 0.424560546875
▁study 2.76171875
▁used 1.3310546875
▁multiple 5.37109375
▁log 0.611328125
istic 0.025848388671875
▁regression 0.280029296875
▁analysis 1.337890625
▁and 2.806640625
▁chose 8.5546875
▁medical 6.1875
▁mar 0.089111328125
iju 0.0009641647338867188
ana 4.601478576660156e-05
▁as 0.56005859375
▁the 0.90087890625
▁control 2.869140625
▁group 0.62939453125
. 0.266357421875
<0x0A> 0.43505859375
The 0.53173828125
▁analysis 3.4609375
▁of 1.00390625
▁any 10.53125
▁human 6.61328125
▁reaction 4.953125
▁has 4.78125
▁a 1.8544921875
▁high 3.04296875
▁potential 3.24609375
▁of 1.685546875
▁subject 2.787109375
iveness 3.740234375
▁and 1.47265625
▁bias 1.626953125
, 1.978515625
▁especially 2.09765625
▁regarding 3.830078125
▁people 5.00390625
▁in 3.5625
▁severe 2.353515625
▁pain 0.51171875
▁and 2.51953125
▁un 5.89453125
stable 1.1455078125
▁emot 0.76904296875
ional 0.061279296875
▁condition 1.7392578125
. 0.06805419921875
▁Perhaps 8.203125
▁some 6.0703125
▁patients 2.1015625
▁tend 5.3984375
▁to 0.009918212890625
▁ex 2.064453125
agger 0.01018524169921875
ate 0.0015630722045898438
▁their 0.8310546875
▁de 3.099609375
press 1.876953125
ive 0.055938720703125
▁state 2.630859375
▁or 1.806640625
▁vice 5.73046875
▁vers 0.032470703125
a 0.00015294551849365234
, 1.111328125
▁de 7.25
- 2.525390625
emph 0.455078125
as 0.00276947021484375
ize 0.06591796875
▁serious 6.875
▁difficulties 5.90234375
. 0.8056640625
▁Because 6.04296875
▁the 2.568359375
▁survey 5.046875
▁responses 7.20703125
▁were 1.1123046875
▁thoroughly 9.1953125
▁anonymous 2.123046875
, 0.24169921875
▁the 0.865234375
▁research 0.82177734375
ers 0.1558837890625
▁were 2.525390625
▁unable 2.14453125
▁to 0.0014715194702148438
▁carefully 7.50390625
▁analyze 2.87890625
▁each 2.572265625
▁patient 2.14453125
’ 0.5341796875
s 0.0011425018310546875
▁reaction 3.982421875
▁and 1.3125
▁compare 3.708984375
▁it 0.89794921875
▁to 0.5615234375
▁the 0.8896484375
▁actual 4.21484375
▁states 8.2421875
▁of 0.55322265625
▁condition 7.07421875
. 0.35693359375
▁More 6.171875
▁accurate 3.173828125
▁answers 4.6015625
▁could 1.751953125
▁be 0.75732421875
▁obtained 0.98095703125
▁by 1.4169921875
▁professional 6.01953125
▁psych 1.0234375
olog 0.377197265625
ists 0.0014133453369140625
▁via 7.1953125
▁personal 2.779296875
▁communication 4.23828125
▁and 2.041015625
▁behavior 6.1484375
al 0.301025390625
▁analysis 1.9462890625
. 0.3037109375
▁However 2.900390625
, 0.0005884170532226562
▁this 1.6767578125
▁method 2.482421875
▁of 2.509765625
▁research 1.7666015625
▁is 1.2666015625
▁way 6.34765625
▁more 1.0029296875
▁resource 4.6171875
- 0.281005859375
int 1.4306640625
ensive 0.02777099609375
▁and 0.423828125
▁energy 11.15625
- 0.08740234375
consum 0.372802734375
ing 0.0017452239990234375
. 0.85302734375
<0x0A> 0.55322265625
This 3.697265625
▁type 5.90234375
▁of 0.00139617919921875
▁study 1.16015625
▁is 1.3671875
▁the 4.2265625
▁most 1.3505859375
▁reve 7.5234375
aling 0.0004622936248779297
▁and 1.4521484375
▁inclus 7.22265625
ive 0.00112152099609375
, 3.15234375
▁as 1.53515625
▁it 0.339111328125
▁contains 4.59765625
▁direct 6.03125
▁responses 4.25
▁from 0.60009765625
▁a 3.17578125
▁large 0.787109375
▁number 0.51708984375
▁of 0.0026950836181640625
▁participants 1.4677734375
. 0.56689453125
▁All 5.3203125
▁tools 9.109375
▁in 5.703125
▁the 0.8701171875
▁form 3.888671875
▁of 0.0240325927734375
▁question 0.775390625
na 0.0171661376953125
ires 2.2649765014648438e-05
▁and 0.8994140625
▁scales 1.9599609375
▁have 3.107421875
▁already 3.923828125
▁been 0.424560546875
▁used 2.744140625
▁and 1.6171875
▁proved 2.36328125
▁their 1.3876953125
▁effic 2.970703125
acy 0.0048370361328125
▁for 3.470703125
▁collect 4.26171875
ing 0.0067138671875
▁analyt 6.734375
ical 0.11309814453125
▁data 0.1905517578125
. 0.364501953125
▁It 3.1328125
▁helps 4.66796875
▁to 0.7119140625
▁system 6.41015625
at 0.599609375
ize 0.0012292861938476562
▁and 1.30078125
▁class 4.7578125
ify 0.00157928466796875
▁distinct 8.0546875
▁kinds 6.62109375
▁of 0.0186767578125
▁information 2.697265625
▁for 4.1328125
▁subsequent 5.0390625
▁un 8.3203125
comp 4.5625
licated 0.027587890625
▁services 12.6640625
. 0.68701171875
▁Thus 4.54296875
, 0.00759124755859375
▁research 4.359375
ers 0.232177734375
▁can 1.712890625
▁compare 2.666015625
▁the 1.119140625
▁effects 3.10546875
▁of 0.07464599609375
▁medic 3.857421875
ations 0.66357421875
▁on 1.59375
▁patients 2.103515625
▁of 3.794921875
▁diverse 2.998046875
▁age 2.0234375
▁groups 2.740234375
, 0.5087890625
▁background 3.77734375
s 0.16650390625
, 0.0192108154296875
▁physical 5.07421875
▁conditions 1.3271484375
, 0.046295166015625
▁emot 5.49609375
ional 0.0160369873046875
▁states 0.970703125
, 0.0570068359375
▁and 0.442626953125
▁so 2.453125
▁on 0.1822509765625
. 0.0777587890625
<0x0A> 1.119140625
Part 5.71484375
icip 0.1583251953125
ants 0.12109375
▁were 1.326171875
▁rec 2.017578125
ru 0.0005030632019042969
ited 3.9696693420410156e-05
▁for 1.810546875
▁six 0.31689453125
▁months 0.006053924560546875
▁at 0.359130859375
▁two 0.07275390625
▁major 0.09527587890625
▁pain 0.038421630859375
▁relief 0.02056884765625
▁cent 0.01236724853515625
ers 0.0006008148193359375
▁in 0.0416259765625
▁Israel 0.00975799560546875
. 0.174072265625
▁All 4.4296875
▁patients 1.513671875
▁experienced 4.16015625
▁chron 0.80712890625
ic 0.0001671314239501953
▁pain 0.1444091796875
▁for 2.546875
▁at 0.66259765625
▁least 0.0019102096557617188
▁ 1.8056640625
3 1.5166015625
▁months 0.228515625
. 1.2373046875
▁The 1.3759765625
▁study 1.701171875
▁included 1.60546875
▁ 0.54541015625
8 2.998046875
9 2.474609375
0 2.904296875
▁participants 1.6494140625
, 1.4189453125
▁of 2.712890625
▁which 0.423583984375
▁ 0.0921630859375
4 1.314453125
7 2.57421875
4 2.611328125
▁( 2.90625
5 0.08599853515625
9 4.94921875
%) 0.77490234375
▁were 0.8740234375
▁treated 3.0234375
▁sole 6.8828125
ly 0.00018334388732910156
▁with 0.2998046875
▁op 1.20703125
io 0.331298828125
ids 0.14306640625
, 0.5615234375
▁ 0.681640625
3 1.2333984375
2 2.263671875
9 2.478515625
▁( 0.041259765625
4 2.5390625
1 1.431640625
%) 0.056549072265625
▁were 1.46875
▁treated 0.568359375
▁with 0.34814453125
▁MM 0.7001953125
, 0.361328125
▁and 0.10760498046875
▁ 0.21533203125
7 2.03125
7 2.556640625
▁( 0.1011962890625
8 1.927734375
. 0.8828125
6 2.44140625
%) 0.06707763671875
▁acquired 10.4921875
▁both 0.5908203125
▁( 5.01953125
Fe 9.5078125
ing 1.2724609375
old 0.4365234375
▁et 1.00390625
▁al 0.01666259765625
., 0.151123046875
▁ 0.0125579833984375
2 0.006046295166015625
0 0.00018322467803955078
1 0.2744140625
7 1.6689453125
). 0.05560302734375
▁The 1.1982421875
▁remaining 7.5625
▁ten 6.81640625
▁participants 1.2939453125
▁who 4.875
▁did 2.265625
▁not 0.00554656982421875
▁receive 2.21875
▁ph 3.80859375
arma 0.084228515625
ce 0.0008530616760253906
ut 9.5367431640625e-07
ical 0.0021381378173828125
▁op 1.23828125
io 0.0433349609375
ids 0.021087646484375
▁and 2.451171875
▁medical 1.5791015625
▁mar 0.036895751953125
iju 0.00023794174194335938
ana 3.898143768310547e-05
▁were 0.45068359375
▁with 6.8203125
dra 0.053558349609375
wn 9.381771087646484e-05
▁from 0.2320556640625
▁the 0.19921875
▁analysis 2.169921875
▁in 5.0703125
▁the 1.111328125
▁research 4.375
. 1.1259765625
▁Therefore 5.06640625
, 0.0088043212890625
▁it 3.9765625
▁is 1.455078125
▁not 3.15234375
▁possible 0.73193359375
▁to 0.0054931640625
▁compreh 6.046875
ens 0.1409912109375
ively 0.0164337158203125
▁compare 1.189453125
▁patients 5.03515625
▁taking 3.748046875
▁medic 4.16015625
ations 0.498779296875
▁with 1.4423828125
▁those 1.0263671875
▁who 0.7626953125
▁do 1.3837890625
▁not 0.0038356781005859375
. 0.61083984375
<0x0A> 0.65185546875
The 0.81103515625
▁study 1.7294921875
▁conducted 4.26171875
▁a 1.6689453125
▁correlation 6.6328125
▁type 9.4296875
▁of 0.216552734375
▁research 0.9970703125
▁with 3.439453125
▁variable 8.5
▁measures 5.09765625
. 0.87939453125
▁It 1.4970703125
▁evaluated 4.6328125
▁the 0.5927734375
▁inter 6.03125
dep 2.359375
end 0.0002493858337402344
ence 0.007404327392578125
▁of 0.59521484375
▁various 3.451171875
▁factors 0.84814453125
▁that 2.921875
▁affected 4.14453125
▁the 0.47119140625
▁physical 6.3671875
▁and 0.273681640625
▁emot 0.43798828125
ional 9.965896606445312e-05
▁condition 1.5087890625
▁of 0.037017822265625
▁patients 0.7392578125
▁experien 2.9765625
cing 6.079673767089844e-06
▁chron 0.2156982421875
ic 0.00014901161193847656
▁pain 0.0106201171875
. 0.1309814453125
▁For 4.12109375
▁example 1.1728515625
, 0.0012454986572265625
▁the 1.0107421875
▁survey 5.390625
▁showed 4.1875
▁that 0.465087890625
▁the 1.8623046875
▁ratio 6.8203125
▁of 0.089111328125
▁female 3.55078125
▁patients 0.95654296875
▁was 1.1875
▁remark 8.0078125
ably 0.0001659393310546875
▁higher 0.176025390625
▁in 2.5859375
▁the 0.48974609375
▁op 3.822265625
i 3.421875
ates 0.01003265380859375
▁group 0.20263671875
▁compared 2.41015625
▁to 0.041259765625
▁the 0.58740234375
▁MM 0.1561279296875
▁group 0.3408203125
. 0.5126953125
▁In 3.408203125
▁turn 3.876953125
, 0.0008630752563476562
▁people 5.01171875
▁on 4.76171875
▁op 3.0546875
i 0.63134765625
ates 0.0034008026123046875
▁were 0.91650390625
▁more 1.3369140625
▁likely 0.294189453125
▁to 0.0228118896484375
▁report 2.845703125
▁major 5.93359375
▁de 0.48486328125
press 0.7109375
ive 0.0020351409912109375
▁dis 0.92626953125
orders 1.6640625
. 1.6748046875
<0x0A> 2.1640625
The 0.87841796875
▁question 5.53515625
na 0.9189453125
ires 5.5670738220214844e-05
▁used 1.80078125
▁different 7.75390625
▁variable 8.6015625
▁measures 0.36669921875
▁to 1.71484375
▁collect 2.384765625
▁information 1.6611328125
. 1.3369140625
▁For 1.7412109375
▁example 0.2900390625
, 0.0014514923095703125
▁it 4.23828125
▁included 1.92578125
▁compreh 8.4375
ensive 0.047882080078125
▁so 5.51953125
cio 0.0011396408081054688
- 0.26611328125
dem 0.10064697265625
ographic 0.06744384765625
▁data 0.8681640625
: 4.859375
▁gender 2.03125
, 0.04693603515625
▁age 0.255615234375
, 0.035369873046875
▁country 4.1875
, 2.77734375
▁type 4.30859375
▁of 0.05914306640625
▁residence 3.796875
▁( 2.42578125
urban 0.76220703125
/ 1.3505859375
r 0.1474609375
ural 0.0006794929504394531
), 0.1846923828125
▁years 6.1484375
▁of 0.174072265625
▁education 0.68603515625
, 0.09112548828125
▁and 1.423828125
▁employ 2.474609375
ment 0.001636505126953125
▁status 0.640625
. 0.159912109375
▁Pat 4.51953125
ients 0.078369140625
▁were 1.1220703125
▁also 0.82861328125
▁asked 0.52734375
▁about 0.99072265625
▁their 0.708984375
▁medical 2.447265625
▁history 0.54052734375
▁over 8.7109375
▁the 0.060760498046875
▁years 4.6484375
▁and 1.6845703125
▁the 1.4951171875
▁current 3.009765625
▁presence 4.98046875
▁of 0.079833984375
▁any 2.263671875
▁severe 3.6640625
▁dise 1.849609375
ases 6.818771362304688e-05
▁such 4.390625
▁as 0.0009703636169433594
▁heart 2.6015625
▁failure 1.6552734375
, 0.319091796875
▁di 1.5732421875
ab 0.0007295608520507812
etes 0.0022563934326171875
, 0.0701904296875
▁ar 4.15625
th 0.1575927734375
rit 0.0227203369140625
is 0.0040740966796875
, 0.024627685546875
▁and 1.185546875
▁so 0.80224609375
▁on 0.050811767578125
. 0.04718017578125
▁The 1.7109375
▁third 6.81640625
▁measure 3.552734375
▁of 2.501953125
▁the 0.6171875
▁question 1.71875
naire 0.264404296875
▁was 1.0966796875
▁indicated 10.7109375
▁by 1.1591796875
▁information 6.765625
▁on 2.03515625
▁any 5.59765625
▁twelve 14.3671875
- 0.2015380859375
month 0.12152099609375
▁and 5.0
▁lifetime 0.6259765625
▁drug 3.3515625
▁and 1.6845703125
▁alco 0.1435546875
hol 5.638599395751953e-05
▁consumption 4.51953125
. 0.415283203125
▁In 3.654296875
▁addition 0.896484375
, 0.18798828125
▁the 0.99169921875
▁record 10.1640625
▁included 1.2568359375
▁a 2.755859375
▁pain 4.5
▁measurement 5.09375
▁scale 0.81640625
▁from 4.296875
▁ 0.492431640625
0 0.284423828125
▁to 0.2364501953125
▁ 0.00530242919921875
1 0.06988525390625
0 0.034088134765625
▁to 3.208984375
▁evaluate 1.5283203125
▁dis 6.02734375
com 0.11590576171875
fort 0.0014352798461914062
▁feelings 8.1875
▁during 4.07421875
▁the 0.2958984375
▁last 1.0693359375
▁month 1.705078125
. 0.2130126953125
<0x0A> 0.4345703125
One 5.0546875
▁of 0.2137451171875
▁the 0.00537872314453125
▁major 3.181640625
▁limitations 3.5546875
▁is 2.52734375
▁the 0.474853515625
▁ins 4.85546875
u 0.052978515625
fficient 0.06695556640625
ly 3.4375
▁high 2.9765625
▁response 3.060546875
▁rate 0.0831298828125
, 2.7109375
▁ 4.26171875
5 1.69921875
7 2.6484375
% 1.7001953125
▁instead 6.2890625
▁of 0.0016832351684570312
▁ 0.564453125
7 1.4248046875
0 0.47119140625
% 1.3525390625
▁( 1.90625
Fe 0.5439453125
ing 0.0011148452758789062
old 0.00026988983154296875
▁et 0.01568603515625
▁al 0.00077056884765625
., 0.00800323486328125
▁ 0.0010366439819335938
2 0.0001386404037475586
0 0.00013875961303710938
1 0.0004520416259765625
7 0.004543304443359375
). 0.01055908203125
▁It 1.8642578125
▁can 3.224609375
▁be 0.53955078125
▁fairly 8.2890625
▁explained 1.24609375
▁by 0.1922607421875
▁the 0.293212890625
▁weak 7.84375
▁focus 6.7421875
▁of 0.7783203125
▁respond 5.47265625
ents 0.1148681640625
▁who 3.634765625
▁have 3.7578125
▁overcome 8.8828125
▁severe 2.00390625
▁pain 0.56103515625
▁sens 7.66796875
ations 0.165283203125
▁and 0.9521484375
▁de 5.12109375
press 0.91796875
ive 0.043182373046875
▁episodes 2.177734375
. 0.56103515625
▁It 2.787109375
▁is 0.6953125
▁not 2.5
▁clear 3.626953125
▁how 1.947265625
▁to 3.6640625
▁use 5.7265625
▁these 2.947265625
▁statistics 3.9140625
, 2.994140625
▁as 0.68408203125
▁they 2.04296875
▁still 5.296875
▁may 4.640625
▁be 1.4091796875
▁relevant 4.64453125
▁for 1.65625
▁the 1.6669921875
▁overall 4.5703125
▁analysis 2.205078125
. 0.7353515625
<0x0A> 1.525390625
Am 6.1640625
ong 0.007717132568359375
▁all 2.56640625
▁participants 1.9208984375
▁in 3.384765625
▁the 0.167724609375
▁study 0.4951171875
, 0.0487060546875
▁ 0.77294921875
4 1.744140625
2 2.611328125
. 1.2685546875
2 2.271484375
% 0.04620361328125
▁suffered 3.88671875
▁from 0.04791259765625
▁de 1.478515625
pression 0.3583984375
, 1.1025390625
▁and 1.240234375
▁ 0.1455078125
3 1.33203125
7 2.3671875
% 2.595703125
▁experienced 2.03515625
▁excess 7.15625
ive 0.0294952392578125
▁anx 0.2347412109375
iety 0.0021381378173828125
. 0.46484375
▁The 1.4931640625
▁pl 10.9765625
ur 0.60595703125
ality 0.0006241798400878906
▁of 0.1212158203125
▁de 2.564453125
press 1.0791015625
ive 0.0213623046875
▁dis 2.31640625
orders 0.06463623046875
▁among 3.1796875
▁patients 1.083984375
▁in 2.90625
▁the 0.314453125
▁op 0.44580078125
i 0.418212890625
ates 0.0013637542724609375
, 9.140625
▁medical 3.6484375
▁mar 0.0252838134765625
iju 0.0005650520324707031
ana 2.2411346435546875e-05
, 0.1712646484375
▁and 0.09466552734375
▁mixed 1.65625
▁OP 11.2578125
MM 4.08203125
▁groups 0.548828125
▁number 9.421875
ed 0.0257110595703125
▁ 0.155029296875
5 1.7451171875
7 2.63671875
. 0.51904296875
1 2.45703125
%, 0.16748046875
▁ 0.002704620361328125
2 2.33984375
2 2.67578125
. 0.110595703125
3 2.26171875
%, 0.046783447265625
▁and 0.051513671875
▁ 0.0016069412231445312
5 1.810546875
1 2.099609375
. 0.15673828125
4 2.13671875
%, 0.1624755859375
▁respectively 0.0208282470703125
. 0.4453125
▁The 1.314453125
▁pl 3.96484375
ur 0.01242828369140625
ality 4.7206878662109375e-05
▁of 0.0261688232421875
▁anx 0.380615234375
iety 0.01702880859375
▁contained 10.8203125
▁ 0.245361328125
4 1.1357421875
8 2.41796875
. 0.18115234375
4 2.181640625
% 2.03515625
▁among 2.603515625
▁OP 5.2890625
▁patients 5.921875
, 0.291015625
▁ 0.08294677734375
2 0.95361328125
1 2.470703125
. 0.10888671875
5 2.107421875
% 0.02569580078125
▁among 0.51611328125
▁MM 0.09112548828125
▁patients 0.3681640625
, 0.0162200927734375
▁and 0.0153350830078125
▁ 0.0247955322265625
3 1.3291015625
8 1.92578125
. 0.12359619140625
7 2.18359375
% 0.01055145263671875
▁among 0.211669921875
▁OP 1.875
MM 0.11590576171875
▁participants 3.177734375
. 0.373046875
▁Pat 5.26953125
ients 0.0175933837890625
▁who 1.8583984375
▁took 2.412109375
▁strong 9.90625
▁op 0.77197265625
i 0.8115234375
ates 0.0023784637451171875
▁were 1.201171875
▁t 10.2109375
ended 1.0234375
▁to 0.007076263427734375
▁place 9.9375
▁their 2.123046875
▁pain 1.6259765625
▁on 1.9697265625
▁a 0.57177734375
▁scale 1.671875
▁of 0.38330078125
▁ 0.0814208984375
9 2.544921875
▁to 2.25390625
▁ 0.00933837890625
1 0.0046539306640625
0 0.005336761474609375
▁( 2.638671875
Fe 0.9013671875
ing 0.0023212432861328125
old 0.0003325939178466797
▁et 0.00469207763671875
▁al 0.0001825094223022461
., 0.006801605224609375
▁ 0.0008249282836914062
2 0.00016164779663085938
0 2.4557113647460938e-05
1 0.0005202293395996094
7 0.0032749176025390625
). 0.0106658935546875
▁They 3.67578125
▁were 1.6181640625
▁also 0.94091796875
▁an 9.6015625
gu 4.9375
ished 0.072998046875
▁em 6.140625
otion 0.0007047653198242188
ally 0.0005359649658203125
▁and 1.0146484375
▁react 7.30078125
ed 0.0232696533203125
▁rad 9.0078125
ically 0.0008435249328613281
▁neg 4.81640625
atively 0.0011205673217773438
▁to 0.1754150390625
▁almost 5.4453125
▁all 1.4931640625
▁survey 3.583984375
▁questions 0.225830078125
. 0.265869140625
▁Pat 3.939453125
ients 0.004322052001953125
▁who 1.220703125
▁took 1.822265625
▁only 4.33984375
▁MM 0.383544921875
▁or 2.728515625
▁mixed 2.525390625
▁medic 1.201171875
ations 0.2034912109375
▁course 13.75
▁had 2.447265625
▁a 1.462890625
▁significantly 2.83984375
▁more 3.296875
▁stable 2.623046875
▁emot 0.93115234375
ional 0.000965118408203125
▁state 0.5615234375
▁and 1.12109375
▁cop 6.60546875
ed 0.0236968994140625
▁with 0.33447265625
▁pain 0.84326171875
▁more 1.896484375
▁manage 6.84765625
able 1.576171875
. 0.275146484375
